Skip to main content
Log in
Adis

Drugs in R&D

Publishing model:
Open access

Overview

Drugs in R&D publishes original research and reviews from all phases of drug development and on clinical use of drugs following approval.

The journal was re-launched in 2010 as the first Open Access journal from Adis, making all content from 2010 onwards freely available online. Pre-2010 content is not available as Open Access. 

Manuscripts accepted for publication by the journal are subject to an article processing charge (APC). Details of the current APC and open access funding and support services are available here.

Drugs in R&D offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information). 

Contact: For more information about the journal, including pre-submission enquiries, please contact Stephen O'Connell at stephen.oconnell@springer.com

Editor
  • Anton van Rensburg

Journal metrics

Journal Impact Factor
2.1 (2024)
5-year Journal Impact Factor
2.5 (2024)
Submission to first decision (median)
8 days
Downloads
363.6k (2024)

Calls for papers

View all calls for papers

Latest articles

Journal updates

  • Digital Features

    Drugs in R&D is able to host a range of digital features, with a number of options available to authors.

Journal information

Electronic ISSN
1179-6901
Print ISSN
1174-5886
Abstracted and indexed in
  1. Baidu
  2. CLOCKSS
  3. CNKI
  4. CNPIEC
  5. Chemical Abstracts Service (CAS)
  6. DOAJ
  7. Dimensions
  8. EBSCO
  9. EMBASE
  10. Gale
  11. Google Scholar
  12. Japanese Science and Technology Agency (JST)
  13. Medline
  14. Naver
  15. OCLC WorldCat Discovery Service
  16. Portico
  17. ProQuest
  18. PubMedCentral
  19. Reaxys
  20. SCImago
  21. SCOPUS
  22. Science Citation Index Expanded (SCIE)
  23. Semantic Scholar
  24. TD Net Discovery Service
  25. Wanfang

© Springer Nature Switzerland AG

Journal navigation